Glutathione efflux associated with a low γ-glutamyl transpeptidase activity in human melanoma cells

British Journal of Dermatology

Volumn 137, Issue 5, 1997, Pages 721-727

  Benathan, M ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINYLDOPA; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; MONOPHENOL MONOOXYGENASE; TRIPEPTIDE;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; ENZYME ACTIVITY; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; MELANOGENESIS; MELANOMA CELL; PRIORITY JOURNAL;

EID: 0030679716     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb01108.x     Document Type: Article

References (34)

1. Meister A. Glutathione, ascorbate and cellular protection. Cancer Res 1994; 54: 1969-75.
2. Dulik DM, Fenselau C. Conversion of melphalan to 4-(glutathionyl) phenylalanine. A novel mechanism for conjugation by glutathione-S-transferases. Drug Metab Dispos 1987; 15: 195-9.
3. Suzukake K, Petro BJ, Vistica DT. Reduction in glutathione content of L-PAM resistant L1210 cells confers drug sensitivity. Biochem Pharmacol 1982; 31: 121-4.
4. Ozols RF, Louie KG, Plowman J et al. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem Pharmacol 1987; 36: 147-53.
5. Andrews PA, Schiefer MA, Murphy MP, Howell SB. Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletion. Chem-Biol Internet 1988; 65: 51-8.
6. Crook TR, Souhami RL, Whyman GD, McLean AEM. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide. Cancer Res 1986; 46: 5035-8.
7. Arrick BA, Nathan CF, Griffith OW, Cohn ZA. Glutathione depletion sensitizes tumor cells to oxidative cytolysis. J Biol Chem 1982; 257: 1231-7.
8. Dethmers JK, Meister A. Glutathione export by lymphoid cells: depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation. Proc Natl Acad Sci USA 1981; 78: 7492-6.
9. Benathan M. Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells. Melanoma Res 1996; 6: 183-9.
10. Benathan M, Labidi F. Cysteine-dependent 5-S-cysteinyldopa formation and its regulation by glutathione in normal epidermal melanocytes. Arch Dermatol Res 1996; 288: 697-702.
11. Hansson J, Edgren M, Ehrsson H et al. Effect of D.L-buthionine-S.R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells. Cancer Res 1988; 48: 19-26.
12. Benathan M, Alvero-Jackson H, Mooy A-M et al. Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells. Melanoma Res 1992; 2: 305-14.
13. Kable EPW, Favier D, Parsons PG. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine. Cancer Res 1989; 49: 2327-31.
14. Prezioso JA, Fitzgerald GB, Wick MM. Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with, 3,4-dihydroxybenzylamine and melphalan. J Invest Dermatol 1992; 99: 289-93.
15. Hansson J, Berhane K, Castro VM et al. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid. Cancer Res 1991; 51: 94-8.
16. Jungnelius U, Hao XY, Skog S et al. Cell cycle dependent sensitivity of human melanoma cells to melphalan is correlated with the activity and cellular concentration of glutathione transferases. Carcinogenesis 1994; 15: 99-103.
17. Meister A. Modulation of intracellular levels of glutathione. In: Biochemical Modulation of Anticancer Agents: Experimental Clinical Approaches (Valeriote F, Baker L, eds). Boston: Martinus Nijhoff. 1986: 245-75.
18. Schadendorf D, Jurgovsky K, Kohlmus CM, Czarnetzki BM. Glutathione and related enzymes in tumor progression and metastases of human melanoma. J Invest Dermatol 1995;105: 109-12.
19. Karg E, Rosengren E, Rorsman H. Hydrogen peroxide as a mediator of dopac-induced effects on melanoma cells. J Invest Dermatol 1991; 96: 224-7.
20. Tate SS, Meister A. Interaction of γ-glutamyltranspeptidase with amino acids, dipeptides, and derivatives and analogs of glutathione. J Biol Chem 1974; 249: 7595-602.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RS. Protein measurements with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
22. Ellman GL, Lysko H. Disulfide and sulfhydryl compounds in TCA extracts of human blood and plasma. J Lab Clin Med 1967; 70: 518-27.
23. Stein AF, Dills RL, Klaassen CD. High-performance liquid chromatographic analysis of glutathione and its thiol and disulfide degradation products. J Chromatogr 1986; 381: 259-70.
24. Ito S, Kato T, Maruta K, Fujita K. Determination of DOPA. dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high-performance liquid chromatography with electrochemical detection. J Chromatogr 1984; 311: 154-9.
25. Ito S, Prota G. A facile one-step synthesis of cysteinyldopas using mushroom tyrosinase. Experientia 1977; 33: 1118-9.
26. Karg E, Odh G, Rosengren E et al. Melanin-related biochemistry of IGR 1 human melanoma cells. Melanoma Res 1991; 1: 5-13.
27. Bannai S, Tateishi N. Role of membrane transport in metabolism and function of glutathione in mammals. J Membrane Biol 1986; 89: 1-8.
28. Mojamdar M, Ichihashi M, Mishima Y. γ-Glutamyl transpeptidase. tyrosinase and 5-S-cysteinyldopa production in melanoma cells. J Invest Dermatol 1983; 81: 119-21.
29. Griffith OW, Novogrodsky A, Meister A. Translocation of glutathione from lymphoid cells that have markedly different γ-glutamyl transpeptidase activities. Proc Natl Acad Sci USA 1979; 76: 2249-52.
30. Gilbert HF. Molecular and cellular aspects of thiol-disulfide exchange. Adv Enzymol 1990; 63: 69-172.
31. Anderson ME, Meister A. Intracellular delivery of cysteine. Methods Enzymol 1987; 143: 313-25.
32. Hanigan MH, Ricketts W. Extracellular glutathione is a source of cysteine for cells that express γ-glutamyl transpeptidase. Biochemistry 1993; 32: 6302-6.
33. Diment S, Eidelman M, Rodriguez GM, Orlow SJ. Lysosomal hydrolases are present in melanosomes and are elevated in melanizing cells. J Biol Chem 1995; 270: 4213-5.
34. Mishima Y. Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulatory factors. Pigment Cell Res 1994; 7: 376-87.